The Conquer Cystic Fibrosis Trust

Board Interlocks (2 shared directors)

Giving Philosophy

As a 100% volunteer-run organisation with no salary or administration costs, they maximise the impact of every dollar by directing all funds to life-saving CF research and services. They value transparency and efficiency in their giving approach.

Tips for Applicants

Approach with clear, direct proposals focused on cystic fibrosis research or direct services for CF patients. Given their volunteer-run nature, demonstrate how your request maximises impact per dollar and aligns with their mission to find a cure.

Notable Grants

• $1,000,000 commitment over five years to the Institute of Respiratory Health for the Conquer Cystic Fibrosis Research Program (started 2015)
• $500,000 donation to the Wal-yan Respiratory Research Centre (Kids Research Institute Australia) for a phage bioreactor facility in WA
• CCF GI Innovation project 2020: Towards understanding gut host-microbe interactions and personalised probiotic therapy in cystic fibrosis using organoid-derived 2D intestinal models (Keith Ooi - via ACFRT)
• CCF Respiratory Innovation project 2022: Establishing a pipeline for repurposing anti-inflammatory drugs to tackle viral-induced exacerbations in children with CF (Samuel Montgomery - via ACFRT)
• CCF Lung Health Transplant Grant 2022: Transforming diagnosis of lung transplant rejection (HLRI - H Ludewick, M Musk, W Pavey, R Brogan, R Labalestier - via ACFRT)
• CCF GI Innovation project 2023: Establishing the utility of GCTM-5 as a biomarker for liver pathology in cystic fibrosis patients (Prof G Yeoh, Prof Ramm, A/Prof Lewindon, Dr Alves and Dr Laing - via ACFRT)
• CCF Lung Health Transplant Grant 2023: Understanding and counteracting antibody-mediated inflammation driving lung damage (T Wells - via ACFRT)

Financial History (7 years)